Target Name: MIR5011
NCBI ID: G100847002
Other Name(s): microRNA 5011 | hsa-miR-5011-5p | hsa-miR-5011-3p | hsa-mir-5011 | MicroRNA 5011

MIR5011: A Drug Target / Disease Biomarker

MIR5011 is a protein that is expressed in various tissues of the body, including the brain, lungs, heart, and kidneys. It is a key regulator of the cell cycle, and its levels have been linked to the development and progression of various diseases, including cancer.

One of the most promising aspects of MIR5011 is its potential as a drug target. Researchers have identified several potential binding sites on the protein that could be targeted by small molecules, leading to the development of compounds that can inhibit its activity. These compounds have been shown to have a variety of biological effects, including inhibiting cell proliferation, migration, and invasion, as well as modulating the expression of genes involved in cell signaling pathways.

In addition to its potential as a drug target, MIR5011 is also a potential biomarker for several types of cancer. Its expression has been observed in a variety of cancer types, including breast, ovarian, and colorectal cancers, and its levels have been linked to the progression of these diseases. This suggests that MIR5011 could be a useful diagnostic or predictive marker for cancer, particularly in the early stages of disease.

The identification and characterization of MIR5011 as a potential drug target and biomarker for cancer has important implications for both basic and clinical research. Understanding how MIR5011 functions and how it can be targeted by small molecules could lead to the development of new treatments for a variety of diseases. Additionally, the characterization of MIR5011 as a potential biomarker for cancer could lead to the development of new diagnostic tools that are more accurate and reliable than currently available.

MIR5011 is a protein that has been identified as a potential drug target and biomarker for cancer. Its expression has been observed in a variety of cancer types and its levels have been linked to the progression of these diseases. Further research is needed to understand how MIR5011 functions and how it can be targeted by small molecules, as well as its potential as a diagnostic tool for cancer.

Protein Name: MicroRNA 5011

More Common Targets

MIR502 | MIR503 | MIR503HG | MIR504 | MIR5047 | MIR505 | MIR506 | MIR507 | MIR508 | MIR5088 | MIR5089 | MIR509-1 | MIR509-2 | MIR509-3 | MIR5090 | MIR5091 | MIR5092 | MIR5093 | MIR5094 | MIR510 | MIR5100 | MIR511 | MIR511-2 | MIR512-1 | MIR512-2 | MIR513A1 | MIR513A2 | MIR513B | MIR513C | MIR514A1 | MIR514A2 | MIR514A3 | MIR514B | MIR515-1 | MIR515-2 | MIR516A1 | MIR516A2 | MIR516B1 | MIR516B2 | MIR517A | MIR517B | MIR517C | MIR5186 | MIR5187 | MIR5188 | MIR5189 | MIR518A1 | MIR518A2 | MIR518B | MIR518C | MIR518D | MIR518E | MIR518F | MIR5190 | MIR5191 | MIR5192 | MIR5193 | MIR5194 | MIR5195 | MIR5196 | MIR5197 | MIR519A1 | MIR519A2 | MIR519B | MIR519C | MIR519D | MIR519E | MIR520A | MIR520B | MIR520C | MIR520D | MIR520E | MIR520F | MIR520G | MIR520H | MIR521-1 | MIR521-2 | MIR522 | MIR523 | MIR524 | MIR525 | MIR526A1 | MIR526A2 | MIR526B | MIR527 | MIR532 | MIR539 | MIR541 | MIR542 | MIR543 | MIR544A | MIR544B | MIR545 | MIR548A1 | MIR548A1HG | MIR548A2 | MIR548A3 | MIR548AA1 | MIR548AA2 | MIR548AC